Grant: DRA : Canada Graduate Research Scholarship - Doctoral Program (CGRS D)
University of British Columbia
$120,000.00
Understanding new human inborn errors of immunity: Translational research in practice
FY 2025-26
Summary
Inborn Errors of Immunity (IEIs) are a group of immune diseases caused by single gene mutations, small mistakes in the genetic code, that disrupt the immune system's protective functions. My doctoral research will help us understand how these diseases occur biologically, and improve the recognition and treatment of affected patients. This work will focus on two diseases: SPENCD (Spondyloenchondrodysplasia) and IRF4 deficiency.
SPENCD patients have overactive immune systems, abnormal bone development, and/or nervous system abnormalities. My work will expand our understanding of how this occurs biologically by linking abnormal protein level/function to patient signs and symptoms. I will also assess a new treatment for these patients, baricitinib, to determine if it can successfully limit inflammation.
IRF4 deficiency is a life-limiting immune disorder, with patients prone to severe, repeated, infections due to poor immune function. I am leading the global collaboration at eight international sites to develop a clear understanding of the recognition, treatment, and outcomes of this disease. Due to the severity of infections, nearly half of the patients have required bone marrow transplants. As two patients have died, our main goal is to improve the survivability of this disease by determining the optimal transplant plan for these patients.
Overall, research to characterize rare, immune-linked pediatric diseases, provides families with answers and improves quality of life. It may also find new treatment options for common diseases, by discoveries made for rare diseases. My work will improve the lives of patients with inborn errors of immunity and contribute to our understanding of the human immune system.
Department
Program
DRA : Canada Graduate Research Scholarship - Doctoral Program (CGRS D)
Recipient
Location
British Columbia, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
560005
Name
Stojcic Mattison P
Region
British Columbia
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Infection and Immunity
Theme2
Biomedical
Prcname2
DT1 (Biomedical and/or Clinical Research) CGRS Doctoral
Projecttitle
Understanding new human inborn errors of immunity: Translational research in practice
Programtype2
Studentship Programs
Orgnameinp2
University of British Columbia
Cihramount2
$120,000
Cihrequipment2
$0
Programname2
DRA : Canada Graduate Research Scholarship - Doctoral Program (CGRS D)
Keyworddelim
Autoimmune; Disease Discovery; Genetics; Immunodeficiency; Immunology; Inborn Errors Of Immunity; Pediatrics; Precision Medicine; Rare Disease; Translational Research
Abstract
Inborn Errors of Immunity (IEIs) are a group of immune diseases caused by single gene mutations, small mistakes in the genetic code, that disrupt the immune system's protective functions. My doctoral research will help us understand how these diseases occur biologically, and improve the recognition and treatment of affected patients. This work will focus on two diseases: SPENCD (Spondyloenchondrodysplasia) and IRF4 deficiency.
SPENCD patients have overactive immune systems, abnormal bone development, and/or nervous system abnormalities. My work will expand our understanding of how this occurs biologically by linking abnormal protein level/function to patient signs and symptoms. I will also assess a new treatment for these patients, baricitinib, to determine if it can successfully limit inflammation.
IRF4 deficiency is a life-limiting immune disorder, with patients prone to severe, repeated, infections due to poor immune function. I am leading the global collaboration at eight international sites to develop a clear understanding of the recognition, treatment, and outcomes of this disease. Due to the severity of infections, nearly half of the patients have required bone marrow transplants. As two patients have died, our main goal is to improve the survivability of this disease by determining the optimal transplant plan for these patients.
Overall, research to characterize rare, immune-linked pediatric diseases, provides families with answers and improves quality of life. It may also find new treatment options for common diseases, by discoveries made for rare diseases. My work will improve the lives of patients with inborn errors of immunity and contribute to our understanding of the human immune system.
Competitiondate
202511
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Stojcic, Mattison P
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $120,000~ $0~